#United States #Washington #Series A Funding #Healthcare Innovation #Chamber Cardiology

Chamber Secures $60 Million in Series A Funding

Chamber, a groundbreaking startup focused on advancing cardiology practices, recently announced the successful raising of $60 million in Series A funding. This funding round, led by Frist Cressey Ventures, saw participation from other prominent investors including General Catalyst, AlleyCorp, American Family Ventures, and many more, marking a significant milestone for the company. The aim of this financial boost is to better support cardiologists and health plans in managing heart disease patients through effective value-based care models.

The infusion of capital will enable Chamber to expand its partnerships with both healthcare plans and cardiology practices, grow into new markets, and bolster its clinical, operational, and technological teams. According to George Aloth, Co-Founder and CEO of Chamber, the company's primary goal is to establish a robust infrastructure that not only helps cardiologists excel in value-based care but also ensures predictable performance for health plans and fosters a superior experience for patients suffering from heart-related issues.

Chamber’s innovative data and intelligence platform is designed specifically for cardiology, streamlining workflows for clinicians by integrating workflow-native AI. This integration facilitates the prioritization of high-risk patients, highlights gaps in adherence to therapy guidelines, and minimizes the need for manual chart reviews. By merging this technology with Chamber’s operational infrastructure, the company aims to lessen avoidable complications and hospital readmissions, ultimately enhancing patient experiences and providing health plans clearer insights into cardiovascular outcomes and overall care costs.

Recognizing the massive volume of data generated by cardiovascular care, Dr. Sameer Sheth, Co-Founder, President, and CMO of Chamber, emphasized that clinicians don't necessarily require more data but instead need clearer signals from it. As cardiovascular diseases continue to be a leading cause of healthcare expenditures and usage in the U.S., the challenge remains that cardiologists must manage aging and high-risk patients while often lacking timely data and support outside of clinic visits. These deficiencies can lead to delayed interventions, missed follow-ups, unnecessary hospitalizations, and increased costs, issues that traditional fee-for-service healthcare systems struggle to resolve.

Frist Cressey Ventures (FCV) highlighted its commitment to investing in transformative companies within critical areas of healthcare, identifying Chamber as an epitome of such innovation. With cardiovascular disease being a major driver of healthcare spending in the U.S., FCV recognizes that the existing fragmented, fee-for-service-driven care structure needs substantial reformation. Chamber’s platform embodies this change by promoting value-based care in cardiology, enhancing patient outcomes, and improving quality of life for individuals and families affected by heart diseases.

Presently, Chamber collaborates with over 500 cardiologists across seven states and is poised for further expansion nationwide. Leveraging its recent funding, Chamber aims to strengthen its market presence and accelerate growth, ensuring that cardiologists can thrive within a value-based healthcare system.

For those interested in learning more about Chamber's mission and initiatives, additional information can be accessed through their official website at www.chambercardio.com.

About Chamber

Founded by healthcare industry veterans George Aloth, Dr. Sameer Sheth, and Dr. Jeffrey De Flavio, Chamber is dedicated to empowering cardiology practices through technology-enabled care delivery. Their focus on value-based care aims to enhance patient outcomes and the overall success of cardiology practices.